Over the past years, Mayoly has been progressively transforming its operating model worldwide to better support our ambition: strengthening our brands, accelerating growth, and operating as one unified, agile, and performance-driven Group.

To further strengthen our competitive position, support sustainable growth, and accelerate the development of our Dermatology business in Russia, we are pleased to announce the integration of our Pharmaceutical and Dermatological business units in Russia into a single, unified organization. This new structure, “OneMayoly Russia”, is effective since January 1st, 2026.

The integrated structure will continue to operate under the leadership of Alla BOGDANOVA, General Manager of Mayoly Pharma in Russia, who will continue to report to Emmanuel PAINT, EVP Global Sales and will work closely with Vincent BERCOVICI, EVP Dermocosmetic to ensure strong alignment in the execution of our global Dermocosmetic strategy.

This integration is designed to significantly accelerate the remarkable performance of our Dermocosmetic business in Russia over past years by combining the specific dermatology know-how and unique Dermo expertise with the scale, capabilities, and operational excellence of our Pharma organization, together with the ambition to grow Topicrem® sustainably.

Under this unification, we enhance portfolio synergiescombining the strengths of our Pharma and Dermo portfolios to offer more comprehensive solutions, furthermore, to boostmarket presenceand increase the visibility and impact of our leading consumer healthcare and dermatology brands, including Topicrem®, Tanakan®, Smecta®, MeteoSpasmyl®, Probiolog®, Pepsane®​, Chophytol®, Fortrans®​, Eziclen®, Forlax®.

This integration represents the rollout in Russia of the operating model that has been successfully implemented in France, where it has demonstrated its ability to strengthen brand impact, improve execution, and support sustainable growth of all brands.

The move towards OneMayoly in Russia is fully aligned with our global strategy. By bringing our business directions together, we strengthen our long-term commitment to the Russian market and increase the impact of our brands for healthcare professionals, partners, and consumers. This step allows us to operate more efficiently and to accelerate our mission of improving everyday life and contributing to the health and well-being of all.

This evolution is a clear reflection of our core values: to perform daily by optimizing our operations, to support carefully by enhancing our service to healthcare professionals and consumers, and to decide responsibly for our long-term success.

We are confident that this strategic integration will position us for continued success in Russia and contribute to the strength of our global company.

No comments yet, be the first to comment.

Leave a Reply